Cotinga Pharmaceuticals Inc. (COT.V) (COT) Stock Price, News & Analysis

Company Overview

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Key Stats

• Today's Range: C$0.04 to C$0.04
• 50-Day Range: C$0.04 to C$0.04
• 52-Week Range: C$0.02 to C$0.12
• Volume: 1,000 shs
• Average Volume: 20,281 shs
• Market Capitalization: C$769,510.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

COT Stock Analysis - Frequently Asked Questions

How have COT shares performed this year?

Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.04 at the start of the year. Since then, COT shares have increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2025 here.

How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)?

Shares of COT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cotinga Pharmaceuticals Inc. (COT.V) investors own include Primo Water (PRMW), Cascades (CAS), Aurora Cannabis (ACB), Advantage Lithium Corp. (AAL.V) (AAL), InPlay Oil (IPO), Harvest One Cannabis (HVT) and Exchange Income (EIF).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:COT
• CIK: N/A
• Web: cotingapharma.com
• Phone: +1-519-8585157
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 17.50
• Book Value: C($0.18) per share
• Price / Book: -0.20

Miscellaneous

• Outstanding Shares: 21,986,000
• Free Float: N/A
• Market Cap: C$769,510.00
• Optionable: Not Optionable
• Beta: N/A